NDA 022113 · Haleon US Holdings
Advil Allergy and Congestion Relief
Chlorpheniramine Maleate, Ibuprofen, Phenylephrine Hydrochloride · Oral · Nonsteroidal Anti-inflammatory Drug
Last checked: Nov 20, 2026Latest source record: Nov 23, 2021 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2011
Dec 21, 2011
Approved uses
2
Original approval plus efficacy supplements
Registered trials
53
11 Phase 3, 4 recruiting
FAERS reports
576
31 serious, 1 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Oct 3, 2025.
Uses temporarily relieves these symptoms associated with the common cold or flu: headache fever minor body aches and pains nasal congestion runny nose sinus pressure sneezing reduces swelling of the nasal passages temporarily restores freer breathing through the nose
Therapeutic areas: Pain and anesthesia
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Apr 28, 2017 Supplement 1 · Efficacy LabelLetter
- Dec 21, 2011 Original approval · Type 4 - New Combination ReviewSummary ReviewLetter
2 products under this application
- ADVIL ALLERGY AND CONGESTION RELIEF · CHLORPHENIRAMINE MALEATE 4MG; IBUPROFEN 200MG; PHENYLEPHRINE HYDROCHLORIDE 10MG · TABLET, ORAL · Over-the-counter
- ADVIL MULTI-SYMPTOM COLD & FLU · CHLORPHENIRAMINE MALEATE 4MG; IBUPROFEN 200MG; PHENYLEPHRINE HYDROCHLORIDE 10MG · TABLET, ORAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Chlorpheniramine" as an intervention, any sponsor and status, largest first.
- Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.Pivotal-lookingRecruiting
Institute of Hematology & Blood Diseases Hospital, ChinaAcademic, hospital or other
NCT04688736 · 6,642 participants (planned) · Start Jan 1, 2021 · Primary completion Dec 31, 2026
Drug: Placebo; Chlorpheniramine · For: Allergic Transfusion Reaction
Sites: Hefei, China; Zhoukou, China; Tai’an, China · 4 sites in all
- Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)Pivotal-lookingCompleted
Organon and CoIndustry
NCT03879772 · 679 participants · Start Mar 12, 1996 · Primary completion Jul 1, 1996
Drug: Mometasone furoate nasal spray; Beclomethasone dipropionate nasal spray and 2 more · For: Rhinitis, Allergic, Seasonal
- Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in AdultsPivotal-lookingRecruiting
Brainfarma Industria Química e Farmacêutica S/AIndustry
NCT07626437 · 620 participants (planned) · Start May 8, 2026 · Primary completion Jun 28, 2027
Drug: dipyrone monohydrate 1000 mg + chlorpheniramine maleate 4 mg + caffeine 60 mg; dipyrone monohydrate 500 mg + chlorpheniramine maleate 2 mg + caffeine 30 mg and 1 more · For: Common Cold/Flu; Nasal Congestion; Nasal Obstruction
Sites: Belo Horizonte, Brazil; Vespasiano, Brazil; Belém, Brazil · 15 sites in all
- Effectiveness Study of Integrative Treatment for Pediatric PneumoniaPivotal-lookingCompleted
Liaoning University of Traditional Chinese MedicineAcademic, hospital or other
NCT02069665 · 451 participants · Start Dec 2011 · Primary completion Jul 2013
Drug: Xiyanping injection; Ribavirin Injection and 6 more · For: Pneumonia
Sites: Beijing, China; Guangzhou, China; Dalian, China · 6 sites in all
- Methods of T Cell Depletion Trial (MoTD)Pivotal-lookingRecruiting
University of BirminghamAcademic, hospital or other
NCT04888741 · 400 participants (planned) · Start Feb 22, 2021 · Primary completion Aug 23, 2027
Drug: Thymoglobulin; Cyclophosphamide and 3 more · For: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelomonocytic Leukemia and 6 more
Sites: Cardiff, United Kingdom; Birmingham, United Kingdom; Bristol, United Kingdom · 17 sites in all
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)Pivotal-lookingCompleted
Cancer Trials IrelandResearch network
NCT01726452 · 377 participants · Start Jan 24, 2013 · Primary completion Aug 4, 2022
Drug: Epirubicin; Cisplatin / Oxaliplatin and 7 more · For: Adenocarcinoma of the Oesophagus; Adenocarcinoma of the Oesophago-gastric Junction; Oesophageal Tumours and 2 more
Sites: Blegdamsvej 9, Denmark; Lille, France; Cork, Ireland · 29 sites in all
- Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common ColdPivotal-lookingStatus unknown
Brainfarma Industria Química e Farmacêutica S/AIndustry
NCT02735070 · 366 participants (planned) · Start Sep 2016 · Primary completion Mar 2017
Drug: Resfenol; Coristina d · For: Cold
- Effect of the Antihistamine Injection to Prevent Paradoxical Reaction During Sedative EndoscopyStatus unknown
Seoul National University HospitalAcademic, hospital or other
NCT03940391 · 220 participants (planned) · Start May 1, 2019 · Primary completion Apr 14, 2020
Drug: Chlorpheniramine and midazolam; Midazolam · For: Endoscopy
Sites: Seoul, South Korea
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective179
- product use in unapproved indication99
- drug effective for unapproved indication89
- somnolence50
- feeling abnormal28
- drug effect incomplete18
- therapeutic product effect incomplete18
- dizziness17
- therapeutic response unexpected16
- dyspnoea15
- fatigue14
- incorrect dose administered14
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2012 | 6 |
| 2013 | 44 |
| 2014 | 52 |
| 2015 | 114 |
| 2016 | 41 |
| 2017 | 17 |
| 2018 | 17 |
| 2019 | 34 |
| 2020 | 41 |
| 2021 | 44 |
| 2022 | 85 |
| 2023 | 59 |
| 2024 | 13 |
| 2025 | 6 |
| 2026 | 3 |
Recalls
1 FDA enforcement reports for this application.
Mar 16, 2020 · Class II · Terminated
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.
Chen SY, Ravindran G, Zhang Q, et al. · CNS Drugs 2019 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Comparative effectiveness of interventions for managing urological postoperative catheter-related bladder discomfort: a systematic review and network meta-analysis.
Ren J, Yu T, Tian Y, et al. · BMC Urol 2023 · Systematic Review, Network Meta-Analysis
- Role of anti-allergic agents on attenuating transfusion reactions in adults: A systematic review and meta-analysis.
Yu S, Gao Y, Walline JH, et al. · Transfus Apher Sci 2021 · Meta-Analysis, Systematic Review
- Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials.
Fornaro M, Caiazza C, Solini N, et al. · Mol Psychiatry 2023 · Systematic Review, Network Meta-Analysis
- Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants.
Schifano F, Chiappini S, Miuli A, et al. · Front Psychiatry 2021 · Systematic Review
- Comparison of Chlorpheniramine Mesotherapy and Oral Gabapentin on Pruritus Caused by Hypertrophic Scars in Burn Patients: A Single-Blind Randomized Controlled Trial.
Setoodehnia Z, Emad M, Jabbedari MH, et al. · J Pain Palliat Care Pharmacother 2026 · Randomized Controlled Trial, Comparative Study
Sponsor: Haleon US Holdings · Also marketed as Advil Multi-Symptom Cold & Flu
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.